1. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway
   Shaoxia Fan et al, 2021, OTT CrossRef
2. The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
   Sepideh Mirzaei et al, 2021, European Journal of Pharmacology CrossRef
3. Radix Tetrastigma extracts enhance the chemosensitivity in triple-negative breast cancer via inhibiting PI3K/Akt/mTOR-mediated autophagy
   Shuo Zhang et al, 2021, Clinical Breast Cancer CrossRef
4. ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities
   Alessandra Monaco et al, 2021, Endocrines CrossRef
5. Light at night and risk of breast cancer: a systematic review and dose-response meta-analysis.
   Marco Vinceti, 0 CrossRef
6. Sex Hormones in Breast Cancer Immunity
   Ebony Hargrove-Wiley et al, 2023 CrossRef
7. Modeling the effects of genetic- and diet-induced obesity on melanoma progression in zebrafish
   Emily Montal et al, 2023 CrossRef
8. null
   Pia Giovannelli et al, 2023 CrossRef
9. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
   Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
10. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer
    Duo Zhang et al, 2024, Front. Cell Dev. Biol. CrossRef
11. Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models
    Janine Kirchner et al, 2024, IJMS CrossRef
12. Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor
    Harika Nagandla et al, 2024, Receptors CrossRef
13. Polygonatum sibiricum component liquiritigenin restrains breast cancer cell invasion and migration by inhibiting HSP90 and chaperone-mediated autophagy
    Suli Xu et al, 2024, Korean J Physiol Pharmacol CrossRef